Why the study?
Does angiotensin-converting enzyme inhibitor-based treatment reduce total cardiovascular events compared to diuretic-based treatment in elderly hypertensive patients?
Does angiotensin-converting enzyme inhibitor-based treatment reduce total cardiovascular events compared to diuretic-based treatment in elderly hypertensive patients?
This paper describes the protocol for the ANBP2 trial, which aims to compare ACE inhibitor-based versus diuretic-based treatment for hypertension in the elderly.
Answers are grounded in this paper and cite their sources.
Protocol for ANBP2 RCT published; leaves open whether ACE inhibitor- or diuretic-based therapy better reduces CV events in elderly hypertension until results emerge.
ANBP2 is a comparative outcome trial of angiotensin-converting enzyme inhibitor- and diuretic-based treatment of hypertension in the elderly using a prospective randomized open-label design with blinding of endpoint assessments. 2. The primary objective is to determine, in hypertensive subjects 65-84 years of age, whether there is any difference in total cardiovascular events (fatal and non-fatal) over a 5 year treatment period between the two treatment regimens. 3. The study is being conducted in general practices throughout Australia and will recruit 6000 subjects over 2-3 years (3000 in each arm of the study) to provide 30,000 years of patient observation. This will allow detection of a 25% difference in the primary outcome variable at the 5% level with a power of 90%. 4. Following randomization to one of the treatment arms, each subject's blood pressure (BP) is managed by the general practitioner according to his/her usual practice to achieve goal BP with guidelines for drug therapy relevant to each treatment arm. 5. Study endpoint information is gained from a review of practice records every 3 months and these data are then assessed by an Endpoint Committee blinded for treatment randomization. 6. Interim analyses of endpoint data will be conducted at the end of randomization and then annually until the final analysis after 5 years of observation in each subject.
No takes yet. Share an insight, caveat, or question.
A 1997 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: